REGISTERED
on 22 Sep 2020
Last Applicant/ Owned by
541 Jefferson Avenue, Suite 100
Redwood City
CA
94063
Serial Number
88299485 filed on 13th Feb 2019
Registration Number
6159041 registered on 22nd Sep 2020
Correspondent Address
James K. Stronski
Filing Basis
1. intent to use
2. use application currently
Disclaimer
NO DATA
ALIBREX
Medical diagnostic assays for testing of bodily fluids, namely, assays used to evaluate the effectiveness of cancer drug therapy and to identify patients who are not responding to cancer drug therapy; Medical diagnostic test media in the form of reagents used to evaluate the effectiveness of cancer drug therapy and to identify patients who are not responding to cancer drug therapy; medical diagnos Read More
Classification Information
Class [042]
Computer & Software Services & Scientific Services
Medical and scientific research in the field of medical diagnostic assays and clinical testing services for the purpose of testing of bodily fluids used to evaluate the effectiveness of cancer drug therapy and to identify patients who are not responding to cancer drug therapy
First Use Date in General
25th Feb 2019
First Use Date in Commerce
25th Feb 2019
Class [005]
Pharmaceutical Products
Medical diagnostic assays for testing of bodily fluids, namely, assays used to evaluate the effectiveness of cancer drug therapy and to identify patients who are not responding to cancer drug therapy; Medical diagnostic test media in the form of reagents used to evaluate the effectiveness of cancer drug therapy and to identify patients who are not responding to cancer drug therapy; medical diagnostic kits comprised of medical diagnostic reagents and assays used to evaluate the effectiveness of cancer drug therapy and to identify patients who are not responding to cancer drug therapy
First Use Date in General
16th Apr 2019
First Use Date in Commerce
16th Apr 2019
Class [044]
Medical, Beauty & Agricultural Services
Medical testing for diagnostic or treatment purposes, namely, for the purpose of testing of bodily fluids used to evaluate the effectiveness of cancer drug therapy and to identify patients who are not responding to cancer drug therapy
First Use Date in General
13th Jan 2020
First Use Date in Commerce
13th Jan 2020
Mark Details
Serial Number
No 88299485
Mark Type
No Service Mark
Attorney Docket Number
No TA278US
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 22nd Sep 2020 | REGISTERED-PRINCIPAL REGISTER |
| 18th Aug 2020 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| 15th Aug 2020 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| 14th Aug 2020 | STATEMENT OF USE PROCESSING COMPLETE |
| 13th Aug 2020 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| 04th Aug 2020 | USE AMENDMENT FILED |
| 04th Aug 2020 | TEAS STATEMENT OF USE RECEIVED |
| 04th Feb 2020 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| 10th Dec 2019 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 10th Dec 2019 | PUBLISHED FOR OPPOSITION |